ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to ...

Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today ...

Publication of positive data in a leading peer-reviewed journal enhances credibility and visibility for FemBloc, attracting interest from the medical community. The reported pregnancy rate of 0% among ...

ATLANTA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (FEMY) (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and ...

If you’re ready to make the life-altering decision to obtain permanent birth control, check out our list of 4 easiest forms of permanent birth control for men and women. While many people are actively ...

Many women spend decades using birth control of one kind or another, except for when they’re trying to conceive or are pregnant. So when you know you’re done having babies or if you plan to stay child ...

ATLANTA, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting women’s unmet needs worldwide by developing a broad portfolio of innovative product ...

FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance --ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Femasys ...

Add Yahoo as a preferred source to see more of our stories on Google. Tom Williams/CQ-Roll Call, Inc/Getty A pro-choice demonstrator in front of the U.S. Supreme Court. The number of women who sought ...